Doman Building Materials Group Ltd. has acquired South Carolina-based CM Tucker Lumber Companies, LLC. The company acquired ...

Initially located in Greensboro, NC, the company expanded its operations to facilities in High Point, Henderson, and ...

I needed a retaining wall. But I didn’t want to abuse my back by schlepping around landscape blocks. Plus, I didn’t want to bust the bank buying good-looking blocks. So after accessing my internal ...

Is it safe to use that green-treated CCA-wood in children's playgrounds, or as fence posts around cattle and other animals? After all, the timber has been soaked in some moderately toxic chemicals ...

It takes time and muscle, but it’s really just a bunch of standard lumber parts screwed together ... wide roof slats from 1x6 material because it was better quality than the 1x3s available at the ...

Founded in 1956 and headquartered in Eighty Four, Pennsylvania, 84 Lumber Company is the nation’s largest privately held supplier of building materials, manufactured components and industry ...

Based on rigorous testing of nine of the best wooden cutting boards, I believe the John Boos Maple Edge-Grain Reversible Cutting Board to be the top all-purpose option for most home cooks.

Transgender hate crime rises by 81% Trans models: From decades of rejection to centre stage Transgender man loses challenge to be named father Video streaming sites and message boards were found ...

I have dyed my hair every color under the sun, so I know a good shampoo for color-treated hair has a lot to get right. I want one that preserves my new color and undoes some of the damage that ...

This form of skin cancer highly treatable if detected early and treated properly, though it can spread to other parts of the body and cause serious health problems if untreated, the American ...

Treated wastewater has been flushing into Fort Lauderdale’s Intracoastal Waterway nonstop since Monday night. The city’s economic engine Port Everglades, multi-million dollar yachts, and ...

The first patient has been treated in a phase 1/2 clinical trial of an experimental Moderna vaccine designed to generate antibodies against PD-L1 and IDO1 – two targets thought to protect ...